Glenmede Trust’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q4
Sell
-2,125
Closed -$18K 2143
2020
Q3
$18K Buy
2,125
+41
+2% +$347 ﹤0.01% 1660
2020
Q2
$24K Sell
2,084
-422
-17% -$4.86K ﹤0.01% 1526
2020
Q1
$23K Hold
2,506
﹤0.01% 2022
2019
Q4
$23K Sell
2,506
-1,400
-36% -$12.8K ﹤0.01% 2022
2019
Q3
$26 Sell
3,906
-1,238
-24% -$8 ﹤0.01% 1922
2019
Q2
$47 Sell
5,144
-12,985
-72% -$119 ﹤0.01% 1705
2019
Q1
$284 Sell
18,129
-95
-0.5% -$1 ﹤0.01% 1056
2018
Q4
$280 Buy
18,224
+2,676
+17% +$41 ﹤0.01% 1005
2018
Q3
$334K Sell
15,548
-38
-0.2% -$816 ﹤0.01% 990
2018
Q2
$379K Sell
15,586
-7,083
-31% -$172K ﹤0.01% 886
2018
Q1
$429K Hold
22,669
﹤0.01% 954
2017
Q4
$429K Sell
22,669
-2,356
-9% -$44.6K ﹤0.01% 954
2017
Q3
$439K Sell
25,025
-5,999
-19% -$105K ﹤0.01% 944
2017
Q2
$995K Hold
31,024
﹤0.01% 769
2017
Q1
$995K Sell
31,024
-13,943
-31% -$447K ﹤0.01% 769
2016
Q4
$1.63M Sell
44,967
-1,014
-2% -$36.7K 0.01% 659
2016
Q3
$2.11M Sell
45,981
-3,476
-7% -$160K 0.01% 619
2016
Q2
$2.48M Sell
49,457
-81,923
-62% -$4.11M 0.02% 580
2016
Q1
$7.03M Sell
131,380
-13,592
-9% -$727K 0.05% 384
2015
Q4
$9.51M Buy
144,972
+26,660
+23% +$1.75M 0.06% 347
2015
Q3
$6.68M Buy
118,312
+31,142
+36% +$1.76M 0.05% 375
2015
Q2
$5.15M Buy
87,170
+15,081
+21% +$891K 0.04% 408
2015
Q1
$4.49M Buy
72,089
+20,444
+40% +$1.27M 0.03% 447
2014
Q4
$2.97M Buy
51,645
+8,290
+19% +$476K 0.02% 492
2014
Q3
$2.33M Buy
43,355
+2,642
+6% +$142K 0.02% 519
2014
Q2
$2.13M Buy
40,713
+664
+2% +$34.8K 0.02% 538
2014
Q1
$2.12M Buy
40,049
+1,743
+5% +$92K 0.02% 543
2013
Q4
$1.53M Sell
38,306
-22,118
-37% -$886K 0.02% 576
2013
Q3
$2.28M Sell
60,424
-6,479
-10% -$245K 0.03% 503
2013
Q2
$2.62M Buy
+66,903
New +$2.62M 0.03% 455